China has developed an antiviral medicine for COVID called JS016
The Institute of Microbiology under the Chinese Academy of Sciences has developed an antiviral medicine for COVID-19, called JS016. The medication is now under phase-III clinical trials and has been used for emergency treatment both domestically and overseas.